0.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
Analyzing net buyer seller activity in Cytosorbents Corporation2025 Price Action Summary & Safe Entry Zone Tips - Newser
Comparing Cytosorbents Corporation in custom built stock radarsRecession Risk & Smart Swing Trading Techniques - Newser
Market reaction to Cytosorbents Corporation’s recent newsTrade Volume Summary & Risk Controlled Stock Pick Alerts - Newser
How sentiment analysis helps forecast Cytosorbents CorporationJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Cytosorbents Corporation stock daily chart insightsTrade Analysis Summary & Weekly High Return Stock Opportunities - Newser
What technical models suggest about Cytosorbents Corporation’s comebackWeekly Investment Report & Verified Short-Term Trading Plans - Newser
Is this a good reentry point in Cytosorbents CorporationMarket Volume Summary & AI Enhanced Trading Alerts - Newser
CytoSorbents provides update of its appeal with FDA regarding DrugSorb-ATR - MSN
How to read the order book for Cytosorbents Corporation2025 Short Interest & Daily Technical Stock Forecast Reports - Newser
How to integrate Cytosorbents Corporation into portfolio analysis toolsMarket Growth Summary & Real-Time Chart Breakout Alerts - Newser
Will Cytosorbents Corporation price bounce be sustainableCEO Change & Free AI Powered Buy and Sell Recommendations - Newser
Sentiment analysis tools applied to Cytosorbents CorporationJuly 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
Is Cytosorbents Corporation forming a reversal patternDollar Strength & Real-Time Buy Signal Alerts - Newser
Pattern recognition hints at Cytosorbents Corporation upsideRecession Risk & Accurate Buy Signal Notifications - Newser
What recovery options are there for Cytosorbents CorporationMarket Growth Summary & Free Fast Gain Swing Trade Alerts - Newser
Cytosorbents (NASDAQ:CTSO) Earns Buy Rating from D. Boral Capital - Defense World
Trade Report: Is Cytosorbents Corporation a play on infrastructure spendingEntry Point & Safe Capital Growth Stock Tips - sundaytimes.kr
CTSO: CytoSorbents announced the De Novo denial on DrugSorb-ATR was upheld by the FDA. However, a path to approval was also provided by the agency. The decision also found no safety issues with DrugSorb-ATR. - Research Tree
FDA upholds denial of CytoSorbents’ DrugSorb-ATR device, offers path forward - Investing.com
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR - Quantisnow
Cytosorbents Corp Q2 2025 Earnings Call Highlights - MSN
Sector ETF performance correlation with Cytosorbents CorporationMarket Trend Summary & Detailed Earnings Play Alerts - Newser
Cytosorbents FY2025 EPS Estimate Boosted by Zacks Small Cap - Defense World
Is now a turning point for Cytosorbents Corporation2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Technical signs of recovery in Cytosorbents CorporationQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - Newser
Will Cytosorbents Corporation continue its uptrendWeekly Trade Analysis & Reliable Entry Point Alerts - Newser
Why Cytosorbents Corporation stock attracts strong analyst attentionJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
Is Cytosorbents Corporation reversing from oversold territory2025 Risk Factors & Long-Term Safe Investment Plans - Newser
Momentum divergence signals in Cytosorbents Corporation chartTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser
How Efficient Is Cytosorbents Corporation at Controlling Operating CostsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):